Gables Capital Management’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,975
| Closed | -$58.6K | – | 448 |
|
|
2024
Q3 | $58.6K | Sell |
10,975
-350
| -3% | -$1.87K | 0.03% | 201 |
|
|
2024
Q2 | $83.6K | Buy |
11,325
+1,600
| +16% | +$11.8K | 0.04% | 170 |
|
|
2024
Q1 | $116K | Buy |
9,725
+2,400
| +33% | +$28.7K | 0.06% | 143 |
|
|
2023
Q4 | $57.7K | Sell |
7,325
-400
| -5% | -$3.15K | 0.04% | 181 |
|
|
2023
Q3 | $34.1K | Buy |
7,725
+4,400
| +132% | +$19.4K | 0.02% | 214 |
|
|
2023
Q2 | $116K | Hold |
3,325
| – | – | 0.08% | 142 |
|
|
2023
Q1 | $72.5K | Hold |
3,325
| – | – | 0.05% | 163 |
|
|
2022
Q4 | $71.8K | Buy |
3,325
+250
| +8% | +$5.4K | 0.05% | 171 |
|
|
2022
Q3 | $75K | Hold |
3,075
| – | – | 0.06% | 161 |
|
|
2022
Q2 | $63K | Buy |
3,075
+750
| +32% | +$15.4K | 0.05% | 182 |
|
|
2022
Q1 | $83K | Buy |
2,325
+2,150
| +1,229% | +$76.8K | 0.05% | 176 |
|
|
2021
Q4 | $5K | Buy |
+175
| New | +$5K | ﹤0.01% | 325 |
|